Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply
Aliment Pharmacol Ther
.
2022 Jan;55(2):258-259.
doi: 10.1111/apt.16721.
Authors
Yuki Tahata
1
,
Ryotaro Sakamori
1
,
Ryoko Yamada
1
,
Takahiro Kodama
1
,
Hayato Hikita
1
,
Hideki Hagiwara
2
,
Yasuharu Imai
3
,
Naoki Hiramatsu
4
,
Shinji Tamura
5
,
Keiji Yamamoto
6
,
Masahide Oshita
7
,
Kazuyoshi Ohkawa
8
,
Taizo Hijioka
9
,
Hiroyuki Fukui
10
,
Toshifumi Ito
11
,
Yoshinori Doi
12
,
Yukinori Yamada
13
,
Takayuki Yakushijin
14
,
Yuichi Yoshida
15
,
Tomohide Tatsumi
1
,
Tetsuo Takehara
1
;
Osaka Liver Forum
Affiliations
1
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
2
Kansai Rosai Hospital, Amagasaki, Japan.
3
Ikeda Municipal Hospital, Ikeda, Japan.
4
Osaka Rosai Hospital, Sakai, Japan.
5
Minoh City Hospital, Minoh, Japan.
6
National Hospital Organization Minami Wakayama Medical Centre, Tanabe, Japan.
7
Osaka Police Hospital, Osaka, Japan.
8
Osaka International Cancer Institute, Osaka, Japan.
9
National Hospital Organization Osaka Minami Medical Centre, Kawachinagano, Japan.
10
Yao Municipal Hospital, Yao, Japan.
11
Japan Community Healthcare Organization Osaka Hospital, Osaka, Japan.
12
Otemae Hospital, Osaka, Japan.
13
Kaizuka City Hospital, Kaizuka, Japan.
14
Osaka General Medical Centre, Osaka, Japan.
15
Suita Municipal Hospital, Suita, Japan.
PMID:
34970764
DOI:
10.1111/apt.16721
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Carcinoma, Hepatocellular* / genetics
Genotype
Hepacivirus / genetics
Hepatitis C, Chronic* / genetics
Humans
Liver Neoplasms* / genetics